Education
About Us
Working with TipRanks
Follow Us
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
RESEARCH TOOLSreports
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.14Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 04, 2025
|% Change Since: -27.11%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including positive clinical trial results, FDA approvals, and strong revenue growth, which were tempered by a net loss for the year and high acquisition costs. The company's strategic initiatives are showing progress, especially in international markets and product pipeline development.Company Guidance
During Cumberland Pharmaceuticals' fourth quarter 2024 call, the company reported strong financial performance with a net revenue of $10.4 million, marking an 11.6% increase compared to the previous year. For the full year, net revenue reached $38 million, with significant contributions from products such as Kristalose ($15.3 million), Sancuso ($9 million), Vibativ ($6.9 million), and Caldolor ($5 million). The company also emphasized its strategic initiatives, including new product developments and international market expansions. Notably, Cumberland achieved regulatory milestones, such as FDA approval for Vibativ in China and a supplemental new drug application for Acetadote. The company has also seen positive Phase 2 trial results for its ifetroban product candidate in Duchenne muscular dystrophy, leading to increased investor interest and a rise in share price. Operating expenses for the year decreased to $44.3 million from the previous year's $49.1 million, with a reported net loss of $6.5 million, although adjusted for non-cash expenses, the loss was reduced to $1.5 million. Cumberland remains focused on growth through strategic acquisitions, expanding its salesforce, and advancing its pipeline, expecting to deliver double-digit revenue growth and positive cash flow from operations in the upcoming year.Positive Phase 2 Study for Ifetroban
Announced positive Phase 2 study data for ifetroban in patients with Duchenne muscular dystrophy, significantly impacting share price and trading volumes.
Vibativ Approval in China
Vibativ received approval by regulatory authorities in China, expanding Cumberland's international business.
Strong Q4 Financial Performance
Fourth-quarter net revenues reached $10.4 million, an 11.6% increase over the prior year period.
Expansion of Kristalose Medicaid Coverage
Kristalose added to Medicaid plans in Virginia, Louisiana, and Maine, contributing to product growth.
Cost Reduction
Total operating expenses for 2024 decreased to $44.3 million, down $5 million from the previous year.
FDA Approvals and Designations
FDA approval for Acetadote's streamlined dosing, orphan drug designation, and rare pediatric disease designation for ifetroban.
---
CPIX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CPIX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 04, 2025 | $6.05 | $6.77 | +11.90% |
| Nov 07, 2024 | $1.20 | $1.19 | -0.83% |
| Aug 06, 2024 | $1.50 | $1.48 | -1.33% |
| May 07, 2024 | $1.58 | $1.67 | +5.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cumberland Pharmaceuticals Inc (CPIX) report earnings?
Cumberland Pharmaceuticals Inc (CPIX) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Cumberland Pharmaceuticals Inc (CPIX) earnings time?
Cumberland Pharmaceuticals Inc (CPIX) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CPIX EPS forecast?
Currently, no data Available
---